Trials / Unknown
UnknownNCT03822988
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The law about advance directives is evolving but, in France, few people write it. Te main endpoint of this research is to estimate the proportion of patients who have written their advance directives or considering doing so in onco-dermatologic population. If this rate remains low, some insights on the reasons will be able to be advanced looking at the point of view and opinion of patients about this topic. Seconds endpoints are : For patients against or not planning to write it, understand their reasons Estimate the proportion of patients requesting information and understand how they would like to receive it. Investigate a possible association between the stage of the oncological disease and the positioning of the patient concerning advance directives.
Conditions
- Advance Directives
- Oncology
- Skin Cancer
- Melanoma
- Skin Lymphoma
- Skin Squamous Cell Carcinoma
- Metastatic Basal Cell Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention, only complete a survey | we will ask patients to answer to a survey |
Timeline
- Start date
- 2019-01-21
- Primary completion
- 2019-06-20
- Completion
- 2019-06-20
- First posted
- 2019-01-30
- Last updated
- 2019-01-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03822988. Inclusion in this directory is not an endorsement.